Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 23, 2025

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

7.2K

Biomarkers in Atopic Dermatitis.

Florence Libon1, Juliette Caron2, Arjen F Nikkels3

  • 1Unit of Dermato-Allergology, Department of Dermatology and Venerology, University Hospital of Liège-Liège, CHU of Sart Tilman, University of Liège, 4000, Liège, Belgium.

Dermatology and Therapy
|June 14, 2024
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overlapping Hyperpigmented and Poikilodermatous Mycosis Fungoides.

Case reports in dermatological medicine·2026
Same author

[Climate change and skin].

Revue medicale de Liege·2026
Same author

Delayed hypersensitivity reaction to cetirizine suggesting involvement of piperazine ring: a case report.

Allergologia et immunopathologia·2026
Same author

Occupational Allergy to Rat and Mouse in Research Laboratories.

Current allergy and asthma reports·2026
Same author

[Vaccination recommendations for psoriasis patients treated with biologics].

Revue medicale de Liege·2025
Same author

Untargeted characterization of dansyl-labeled short peptides up to four amino acids in protein hydrolysates by LC-MS/MS.

Food research international (Ottawa, Ont.)·2025
Same journal

The Impact of Chronic Spontaneous Urticaria on Sleep-A Systematic Review.

Dermatology and therapy·2026
Same journal

Effectiveness, Safety, and Drug Survival of Bimekizumab in Chronic Plaque Psoriasis over 2 Years: Real-World Experience from Northern Italy.

Dermatology and therapy·2026
Same journal

Abrocitinib Achieves Early and Complete/Near-Complete Skin Clearance Plus Itch-Free State in Atopic Dermatitis: Phase 3 Pooled Post Hoc Analysis.

Dermatology and therapy·2026
Same journal

Letter to the Editor Regarding "Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis".

Dermatology and therapy·2026
Same journal

Correction: Dermatologists' Perspectives and Real-World Assessment of Alopecia Areata Severity in Adults in Taiwan: A Cross-sectional Survey.

Dermatology and therapy·2026
Same journal

A Response to: "Letter to the Editor Regarding 'Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis'".

Dermatology and therapy·2026
See all related articles

Biomarkers are crucial for diagnosing and managing atopic dermatitis (AD). Further research is needed to integrate these biomarkers into personalized treatment strategies for AD patients.

Area of Science:

  • Dermatology
  • Immunology
  • Genetics

Background:

  • Atopic dermatitis (AD) is a chronic inflammatory skin disease.
  • Its development involves genetic, environmental, immunological factors, and epidermal barrier dysfunction.
  • Biomarkers are essential for AD diagnosis, severity assessment, and treatment monitoring.

Purpose of the Study:

  • To review current biomarkers for atopic dermatitis (AD).
  • To explore the relationship between biomarkers and different AD phenotypes and endotypes.
  • To highlight the need for further research in AD biomarker development for personalized medicine.

Main Methods:

  • Literature review of existing studies on AD biomarkers.
  • Categorization of biomarkers into diagnostic, prognostic, severity, and stratification types.
Keywords:
Atopic dermatitisBiomarkersDiagnosisEndotypePersonalized treatmentPrognosis

More Related Videos

Author Spotlight: Effective Reuse of Polycarbonate Tubes for Extracellular Vesicle Isolation
02:36

Author Spotlight: Effective Reuse of Polycarbonate Tubes for Extracellular Vesicle Isolation

Published on: March 8, 2024

944
A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
08:02

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

Published on: March 24, 2023

3.4K

Related Experiment Videos

Last Updated: Jun 23, 2025

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

7.2K
Author Spotlight: Effective Reuse of Polycarbonate Tubes for Extracellular Vesicle Isolation
02:36

Author Spotlight: Effective Reuse of Polycarbonate Tubes for Extracellular Vesicle Isolation

Published on: March 8, 2024

944
A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
08:02

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

Published on: March 24, 2023

3.4K
  • Analysis of biomarker relevance across diverse AD phenotypes and endotypes.

    • Main Results:

    • Biomarkers show potential for personalized treatment approaches in AD.
    • Current therapeutic advancements include interleukin (IL) antagonists and Janus kinase (JAK) inhibitors.
    • Significant research gaps remain in establishing the role of biomarkers in AD diagnosis and prognosis.

    Conclusions:

    • Biomarkers are key to advancing personalized medical care for atopic dermatitis (AD).
    • Further investigation is required to fully elucidate the diagnostic and prognostic value of biomarkers in AD.
    • Integrating biomarkers will enhance the scientific basis for tailored AD treatments.